Superworth

Bausch Health Companies EV/EBIT BHC

Enterprise value divided by operating profit over the last twelve months, one-off items taken out, since 2011.

Today, Oct 23, 2026
10.2×
10-year median
26.4×
Against its 10-year history
2nd
percentile: 0 is its lowest day, 100 its highest
10-year range
10.1× to 126×
Peer median
10.5×

Bausch Health Companies' EV/EBIT is 10.2× as of Oct 23, 2026.

That is below its ten-year median of 26.4×, lower than on 98% of days in the last ten years.

Over that time it ranged from 10.1× in Sep 2026 to 126× in Oct 2018.

The median for 10 large drugmakers of a similar size is 10.5×.

EV/EBIT over time

The dashed line is the 10-year median and the shaded band the middle half of its days.

Open the interactive chart, with overlays and comparisons

Year by year

YearEnd of yearLowHigh
2026 so far10.2×10.1×12.4×
202512.2×12.0×18.1×
202418.1×18.0×31.0×
202330.8×22.3×31.2×
202222.5×18.1×44.2×
202144.5×30.7×64.9×
202030.0×23.0×36.6×
201936.4×35.0×78.5×
2018123×21.7×126×
201722.4×20.9×36.5×
201617.8×17.4×28.3×
201529.1×25.1×50.5×
201432.8×30.2×169×
201388.3×59.8×88.6×
201258.5×54.6×64.3×
201155.5×51.2×92.3×

Against its peers

Companies in Drug Manufacturers - General nearest Bausch Health Companies' size, closest first, today.

Where Bausch Health Companies ranks

What the EV/EBIT tells you

What the whole business costs against its operating profit. Enterprise value is the market value plus borrowings and minority interests, less cash. EBIT is operating profit before interest and tax, with one-offs taken out. Unlike PE it is not moved by how a company is financed.

Leases are left out of debt for every company. Banks earn on their balance sheet, so EV/EBIT does not describe them.

More on Bausch Health Companies

Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.